Q: This looks like a great opportunity to own a, if not the, leader in genetic testing and data, but it appears they will be losing money for several more years. Based on the current share value, do you have an opinion on the valuation and risk of investing in VGAC? Do you think it puts 23andme in play for Google or similar tech/medical giant?
Thanks!